Universitätsklinik Köln - Children
Welcome,         Profile    Billing    Logout  
 3 Trials 
9 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Weber, Lutz T
PREDICT, NCT02021006: Antibiotic Prophylaxis and Renal Damage In Congenital Abnormalities of the Kidney and Urinary Tract

Active, not recruiting
3
292
Europe
nitrofurantoin, Furadantin, No prophylaxis, Amoxicillin-Potassium Clavulanate Combination, amoxicilline/clavulanic acid, augmentin, clavulin, Trimethoprim/sulfamethoxazole, bactrim, Cefixime, cefixoral
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Ministero della Salute, Italy, IL Sogno di Stefano
Vesicoureteral Reflux, Renal Hypodysplasia, Nonsyndromic, 1, Chronic Kidney Disease
01/20
01/25
Pro-Tac, NCT06057545 / 2019-003710-13: Pharmacokinetics, Effectiveness and Tolerability of Prolonged-release Tacrolimus After Paediatric Kidney Transplantation

Recruiting
3
30
Europe
Envarsus®, Prograf
University Hospital, Essen, Chiesi GmbH
Pediatric Kidney Disease
12/24
03/25
DOUBLE_PROTECT, NCT05944016: Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients

Recruiting
3
102
Europe
Dapagliflozin, Placebo
University Hospital Goettingen, German Research Foundation
Chronic Kidney Failure in Children and Young Adults
09/26
12/26
FOrMe, NCT03949972: The Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)

Recruiting
N/A
500
Europe
Biosampling
Prof. Dr. Paul Brinkkoetter, German Research Foundation, Medical Faculty and the Faculty of Natural Sciences of the University of Cologne, Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases, Cologne Center for Genomics
Glomerulosclerosis, Focal Segmental, Minimal Change Disease, Idiopathic Nephrotic Syndrome
03/28
03/33
Hansen, Matthias
DOUBLE_PROTECT, NCT05944016: Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients

Recruiting
3
102
Europe
Dapagliflozin, Placebo
University Hospital Goettingen, German Research Foundation
Chronic Kidney Failure in Children and Young Adults
09/26
12/26
Kohl, Stefan
DOUBLE_PROTECT, NCT05944016: Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients

Recruiting
3
102
Europe
Dapagliflozin, Placebo
University Hospital Goettingen, German Research Foundation
Chronic Kidney Failure in Children and Young Adults
09/26
12/26
FOrMe, NCT03949972: The Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)

Recruiting
N/A
500
Europe
Biosampling
Prof. Dr. Paul Brinkkoetter, German Research Foundation, Medical Faculty and the Faculty of Natural Sciences of the University of Cologne, Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases, Cologne Center for Genomics
Glomerulosclerosis, Focal Segmental, Minimal Change Disease, Idiopathic Nephrotic Syndrome
03/28
03/33
Richard, Klaus
DOUBLE_PROTECT, NCT05944016: Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients

Recruiting
3
102
Europe
Dapagliflozin, Placebo
University Hospital Goettingen, German Research Foundation
Chronic Kidney Failure in Children and Young Adults
09/26
12/26
Latta, Kay
DOUBLE_PROTECT, NCT05944016: Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients

Recruiting
3
102
Europe
Dapagliflozin, Placebo
University Hospital Goettingen, German Research Foundation
Chronic Kidney Failure in Children and Young Adults
09/26
12/26

Download Options